These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 37147766)

  • 1. Farnesoid X receptor regulators from natural products and their biological function.
    Wan P; Hengfan NI; Dale G; Yun D; Manyun D
    J Tradit Chin Med; 2023 Jun; 43(3):618-626. PubMed ID: 37147766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly potent non-steroidal FXR agonists protostane-type triterpenoids: Structure-activity relationship and mechanism.
    Luan ZL; Huo XK; Dong PP; Tian XG; Sun CP; Lv X; Feng L; Ning J; Wang C; Zhang BJ; Ma XC
    Eur J Med Chem; 2019 Nov; 182():111652. PubMed ID: 31494470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Products Targeting Liver X Receptors or Farnesoid X Receptor.
    She J; Gu T; Pang X; Liu Y; Tang L; Zhou X
    Front Pharmacol; 2021; 12():772435. PubMed ID: 35069197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alisma orientale extract exerts the reversing cholestasis effect by activation of farnesoid X receptor.
    Huo XK; Liu J; Yu ZL; Wang YF; Wang C; Tian XG; Ning J; Feng L; Sun CP; Zhang BJ; Ma XC
    Phytomedicine; 2018 Mar; 42():34-42. PubMed ID: 29655695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural products as modulators of the nuclear receptors and metabolic sensors LXR, FXR and RXR.
    Hiebl V; Ladurner A; Latkolik S; Dirsch VM
    Biotechnol Adv; 2018 Nov; 36(6):1657-1698. PubMed ID: 29548878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive review of natural products to fight liver fibrosis: Alkaloids, terpenoids, glycosides, coumarins and other compounds.
    Ma X; Jiang Y; Wen J; Zhao Y; Zeng J; Guo Y
    Eur J Pharmacol; 2020 Dec; 888():173578. PubMed ID: 32976828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Licraside as novel potent FXR agonist for relieving cholestasis: structure-based drug discovery and biological evaluation studies.
    Xi L; Shi A; Shen T; Wang G; Wei Y; Guo J
    Front Pharmacol; 2023; 14():1197856. PubMed ID: 37397498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.
    Gao X; Fu T; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Huo X; Yang X; Zou M; Meng Q
    Toxicol Appl Pharmacol; 2018 Jun; 348():105-116. PubMed ID: 29660435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of Natural Products as Novel and Potent FXR Antagonists by Virtual Screening.
    Diao Y; Jiang J; Zhang S; Li S; Shan L; Huang J; Zhang W; Li H
    Front Chem; 2018; 6():140. PubMed ID: 29761098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural products for the prevention and treatment of cholestasis: A review.
    Ma X; Jiang Y; Zhang W; Wang J; Wang R; Wang L; Wei S; Wen J; Li H; Zhao Y
    Phytother Res; 2020 Jun; 34(6):1291-1309. PubMed ID: 32026542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of selective farnesoid X receptor agonists for the treatment of hyperlipidemia from traditional Chinese medicine based on virtual screening and in vitro validation.
    Chen X; Lu F; Luo G; Ren Y; Ma J; Zhang Y
    J Biomol Struct Dyn; 2020 Sep; 38(15):4461-4470. PubMed ID: 31842697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hesperidin alleviates cholestasis via activation of the farnesoid X receptor in vitro and in vivo.
    Zhang G; Sun X; Wen Y; Shi A; Zhang J; Wei Y; Wu X
    Eur J Pharmacol; 2020 Oct; 885():173498. PubMed ID: 32841642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel farnesoid X receptor agonist, kaempferol-7-O-rhamnoside, a compound ameliorating drug-induced liver injury based on virtual screening and in vitro validation.
    Liu K; Chen X; Ren Y; Liu C; Yuan A; Zheng L; Li B; Zhang Y
    Toxicol Appl Pharmacol; 2022 Nov; 454():116251. PubMed ID: 36150480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Farnesoid X receptor modulators (2011 - 2014): a patent review.
    Sepe V; Distrutti E; Fiorucci S; Zampella A
    Expert Opin Ther Pat; 2015; 25(8):885-96. PubMed ID: 26183029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Makisterone A attenuates experimental cholestasis by activating the farnesoid X receptor.
    Kang P; Li S
    Biochem Biophys Res Commun; 2022 Oct; 623():162-169. PubMed ID: 35921707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational modulation of the farnesoid X receptor by prenylflavonoids: Insights from hydrogen deuterium exchange mass spectrometry (HDX-MS), fluorescence titration and molecular docking studies.
    Yang L; Broderick D; Campbell Y; Gombart AF; Stevens JF; Jiang Y; Hsu VL; Bisson WH; Maier CS
    Biochim Biophys Acta; 2016 Dec; 1864(12):1667-1677. PubMed ID: 27596062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Sedi Herba (Sedum sarmentosum) on attenuating cholestasis by the activation of the farnesoid x receptor (FXR)-mediated signaling.
    Liu Z; Liu D; Chen M; Zong W; Zhou X; Meng F; Jiang Y; Chen M; Liao Z; Wang G
    Biomed Pharmacother; 2022 Nov; 155():113803. PubMed ID: 36271579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery that theonellasterol a marine sponge sterol is a highly selective FXR antagonist that protects against liver injury in cholestasis.
    Renga B; Mencarelli A; D'Amore C; Cipriani S; D'Auria MV; Sepe V; Chini MG; Monti MC; Bifulco G; Zampella A; Fiorucci S
    PLoS One; 2012; 7(1):e30443. PubMed ID: 22291955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease.
    Wu W; Zhu B; Peng X; Zhou M; Jia D; Gu J
    Biochem Biophys Res Commun; 2014 Jan; 443(1):68-73. PubMed ID: 24269813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research Progress of Natural Active Substances with Immunosuppressive Activity.
    Shao F; Shen Q; Yang Z; Yang W; Lu Z; Zheng J; Zhang L; Li H
    Molecules; 2024 May; 29(10):. PubMed ID: 38792220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.